Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
medmix AG ( (CH:MEDX) ) has shared an update.
medmix AG has been recognized as one of only nine Swiss companies to achieve an ‘A’ score in CDP’s annual climate change assessment, highlighting its leadership in environmental performance. This recognition underscores medmix’s commitment to integrating environmental principles across its operations and its strategic focus on sustainable innovation, aiming to set new benchmarks for environmental responsibility in the industry.
The most recent analyst rating on (CH:MEDX) stock is a Buy with a CHF18.00 price target. To see the full list of analyst forecasts on medmix AG stock, see the CH:MEDX Stock Forecast page.
More about medmix AG
medmix is a global leader in high-precision delivery devices, serving healthcare, consumer, and industrial markets. The company is known for its innovation and technological advancements, boasting over 900 active patents and operating 14 production sites worldwide. Headquartered in Baar, Switzerland, medmix is publicly traded on the SIX Swiss Exchange.
Average Trading Volume: 58,566
Current Market Cap: CHF433.3M
For a thorough assessment of MEDX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue